George Scorsis
Independent Chairman of the BoardMr. George Scorsis is Director of XORTX Therapeutics Inc. from March 24, 2026. Mr. Scorsis is Independent Director of Shuttle Pharmaceuticals Holdings, Inc. from February 2025 and serves as its Independent Chairman of the Board since June 2025. Mr. Scorsis has been Executive Chair of Entourage Health Corp. (formerly known as WeedMD Inc.) since December 23, 2019 and its Chief Executive Officer since February 11, 2022. Mr. Scorsis serves as Director at PlantFuel Life Inc. since November 01, 2022 and Atelier Meats Corp., since February 13, 2023. From January 2015 to April 2018, Mr. Scorsis has served as Chairman of the Board of Directors of SOL Global Investments Corp. He serves as Chairman of the Board at Solvonis Therapeutics plc (formerly known as Awakn Life Sciences Corp.) since May 21, 2020. He is a co-founder of Solvonis Therapeutics plc (formerly known as Awakn Life Sciences Corp.) and serves as its Director since May 21, 2020. He has experience leading companies in highly regulated industries to rapid growth, including alcohol, energy drinks and most recently, medical cannabis. He has commercial experience in the consumer packaged goods (CPG), beverage and the cannabis industries. He was an Interim Chief Executive Officer of Entourage Health Corp. from January 4, 2021 until February 11, 2022. He was the Chief Executive Officer of Liberty Health Sciences Inc. from July 24, 2017 to February 22, 2019 and its Director since July 24, 2017 until February 2019. He was the Chairman of the Board of Scythian Biosciences Corp. since April 25, 2018 until July 26, 2018. He was Lead Director at Scuthian Biosciences Corp. since March 2018 until April 25, 2018 and was its Director since January 15, 2018 until July 26, 2018. Mr. Scorsis served as President of Red Bull Canada from July 2011 until October 2015 and was instrumental in restructuring the organization from a geographical and operational perspective and growing the business. He was responsible for each Red Bull Canada?s financial performance. As President, he worked closely with Health Canada on guidelines regulating the energy drink product category. He has also worked closely with Health Canada on guidelines regulating the energy drink category while also establishing a corporately owned distribution model in volatile markets. Most recently, he served as President of Mettrum Health Corp. from October 2015 to July 2017 and was fundamental in shaping MettrumTM and Mettrum OriginalsTM. From July 2017 to February 2019, Mr. Scorsis served as the Chief Executive Officer and Director of Liberty Health Sciences. He worked as a University Ambassador for Bacardi Canada and held several executive roles. Mr. Scorsis holds Bachelor in Administrative Studies from York University and an MBA from Queens University.
Positions
- Company NameShuttle Pharmaceuticals Holdings, Inc.Stock CodeSHPHPositionIndependent Chairman of the BoardColleagues
- CRChristopher Robert CooperInterim Co-CEO & Director
- MBMilton BrownCo-Founder
- RTRyan TrasoliniCo-Chief Executive Officer
- MJMira JungCo-Founder & Chief Scientific Officer for Biology
- YLYuying LiangChief Financial Officer
- TLTheodore L. PhillipsChairman of Scientific Advisory Committee
- ALAngel LirianoIndependent Director
- JMJ. Martin BrownMember of Scientific Advisory Committee
